Yunfan Sun1, Liang Wu2, Yu Zhong3

  • 1Department of Liver Surgery & Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China; Zhong-Hua Precision Medical Center, Zhongshan Hospital, Fudan University-BGI, Shanghai 200032, China.

Cell
|December 28, 2020
PubMed
概括

肝细胞癌复发涉及明显的免疫细胞变化,复发瘤显示更多与先天类似的CD8+ T细胞与更糟糕的结果相关. 了解这些免疫逃避机制是新疗法的关键.